Cetera Investment Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Buy
37,456
+11,741
+46% +$3.12M 0.02% 811
2026
Q1
$2.82M Buy
25,715
+429
+2% +$61.1K ﹤0.01% 1962
2025
Q4
$4.21M Buy
25,286
+6,928
+38% +$1.16M ﹤0.01% 1589
2025
Q3
$3.59M Buy
18,358
+9,227
+101% +$1.52M ﹤0.01% 1679
2025
Q2
$826K Buy
9,131
+5,712
+167% +$451K ﹤0.01% 2546
2025
Q1
$204K Sell
3,419
-54
-2% -$5K ﹤0.01% 3585
2024
Q4
$460K Buy
+3,473
New +$326K ﹤0.01% 2749

Other funds holding ALAB

Cetera Investment Advisers's ALAB Position: Q2 2026 in Review

Cetera Investment Advisers increased its Astera Labs (ALAB) stake by 46% in Q2 2026, buying an estimated $3.12M and bringing the position to 37,456 shares worth $18.1M. The position accounts for 0.02% of the portfolio, ranked #811.

Cetera Investment Advisers first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 990 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Cetera Investment Advisers held 37,456 shares of Astera Labs worth $18.1M as of Q2 2026.
  • Cetera Investment Advisers bought 11,741 Astera Labs shares in Q2 2026, an estimated $3.12M.
  • Astera Labs made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #811 holding.
  • Cetera Investment Advisers first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 990 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.